Agalsidase beta treatment slows estimated glomerular filtration rate loss in classic Fabry disease patients: results from an individual patient data meta-analysis.
Clin Kidney J
; 14(4): 1136-1146, 2021 Apr.
Article
en En
| MEDLINE
| ID: mdl-33841859
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Systematic_reviews
Idioma:
En
Revista:
Clin Kidney J
Año:
2021
Tipo del documento:
Article